Disclosure of Hong Kong Stock Shareholders' Rights | September 12
According to data from the Zhitong Finance App, Shisi Pharmaceutical Group (02005), Kangzhe Pharmaceutical (00867), Liankang Biotechnology Group (00690), and Weisheng Holdings (03393) made the latest shareholders' rights disclosure on September 12, 2024.
Stock name | Name of institution | nature | Shareholding before the change | Shareholding after the change | Shareholding ratio |
---|---|---|---|---|---|
Shisi Pharmaceutical Group (02005) | China Pharmaceutical Company Limited | Yoshikura | 0.844 billion shares | 0.846 billion shares | 28.50% (latest) 28.41% (previous) |
Kangzhe Pharmaceutical (00867) | Treasure Sea Limited | Yoshikura | 1.163 billion shares | 1.164 billion shares | 47.70% (latest) 47.68% (previous) |
Liankang Biotechnology Group (00690) | Zhao Zhigang | Yoshikura | 94.735 million shares | 93.175 million shares | 1.51% (latest) 1.54% (previous) |
Liankang Biotechnology Group (00690) | Leung Kwok Lung | Yoshikura | 1.68 billion shares | 1.677 billion shares | 27.21% (latest) 27.26% (previous) |
Weisheng Holdings (03393) | Jiwei | Yoshikura | 0.536 billion shares | 0.536 billion shares | 53.85% (latest) 53.81% (previous) |
Kangzhe Pharmaceutical (00867) | Lin Gang | Yoshikura | 1.163 billion shares | 1.164 billion shares | 47.70% (latest) 47.68% (previous) |
Shisi Pharmaceutical Group (02005) | Qu Jiguang | Yoshikura | 1.129 billion shares | 1.131 billion shares | 38.11% (latest) 38.02% (previous) |